Spike Protein and Brain Fog: What Research Actually Says

The honest state of brain-fog research

"Brain fog" is one of the most-reported persistent symptoms in long-COVID surveys, but the underlying biology is still being worked out. The literature is busy, contradictory, and almost entirely preliminary. Headlines that describe "the cause" of brain fog are usually overstating the data.

Several converging lines of evidence make the picture more concrete than it was in 2020. A 2022 paper in Nature by Douaud and colleagues used pre- and post-infection MRI from the UK Biobank to document measurable changes in brain structure after even mild COVID-19, including reductions in gray matter and changes in regions connected to olfaction and memory. A 2024 paper in Cell by Greene and colleagues documented blood-brain-barrier disruption in long-COVID patients with cognitive symptoms.

Other groups are studying microclots, persistent viral protein in tissue, and vagus-nerve dysfunction. None of these is a settled mechanism. They are competing and overlapping hypotheses, and the field has not yet reached consensus on how much each contributes — or whether different patients have meaningfully different underlying biology.

The honest summary: most patients with post-COVID brain fog improve substantially within months. A smaller subset has more persistent symptoms that deserve careful clinical evaluation. Researchers are mapping the mechanisms, but cures and clearance treatments are not currently part of the peer-reviewed literature.

What "brain fog" actually means

Brain fog is a descriptive term, not a diagnosis. Patients use it for a cluster of cognitive symptoms that researchers more carefully describe as deficits in:

• Attention and concentration — difficulty sustaining focus on reading, conversations, or tasks.
• Processing speed — thinking feels slowed; decisions take longer.
• Working memory — trouble holding information in mind while using it.
• Word retrieval — "tip-of-the-tongue" moments become more frequent.
• Mental fatigue — cognitive tasks deplete energy faster than they did before.

A 2022 paper in JAMA Network Open by Becker and colleagues showed measurable deficits in processing speed and executive function on standardized neuropsychological testing in post-COVID patients with subjective cognitive complaints. The sizes of these deficits were small to moderate at the population level but clinically meaningful for individuals.

Five mechanisms researchers are studying

1. Neuroinflammation

Post-mortem studies and PET-imaging research have documented activated microglia — the brain's immune cells — in some long-COVID patients with cognitive symptoms. A 2022 paper in Brain by Yang and colleagues described persistent microglial activation in COVID-affected brain tissue. Neuroinflammation is the most-studied candidate mechanism and is the basis for several ongoing trials of anti-inflammatory interventions.

2. Microclots and microvascular damage

Researchers led by Resia Pretorius at Stellenbosch University, in work published across several journals including Cardiovascular Diabetology, have documented fibrin amyloid microclots in long-COVID blood samples. The hypothesis is that these microclots impair small-vessel circulation, including in the brain. The methodology and clinical relevance remain debated, but the hypothesis is actively being tested in larger studies.

3. Blood-brain-barrier disruption

The 2024 Cell paper by Greene and colleagues used dynamic contrast-enhanced MRI to demonstrate increased blood-brain-barrier permeability in long-COVID patients with brain fog, but not in matched controls without cognitive symptoms. This is one of the strongest pieces of evidence that brain fog has a biological signature, not just a psychological one.

4. Persistent viral antigens

Research groups including the Iwasaki lab at Yale and the Putrino lab at Mount Sinai have reported detection of SARS-CoV-2 spike protein and viral RNA in tissue and plasma months after acute infection in some long-COVID patients. The clinical significance — whether persistent antigen drives symptoms, or is incidental — is the central open question driving NIH RECOVER-funded antiviral trials.

5. Autonomic dysfunction and the vagus nerve

A subset of long-COVID patients meets criteria for postural orthostatic tachycardia syndrome (POTS) and other dysautonomias. Vagus-nerve dysfunction has been documented in research from the University of Barcelona group led by Acosta-Ampudia. Autonomic involvement may explain why brain fog often co-occurs with palpitations, exercise intolerance, and sleep disruption.

What the published studies show

What this does not mean

• This is not a diagnostic article. Cognitive symptoms have many causes (sleep apnea, thyroid disease, depression, medication side effects, perimenopause, B12 deficiency) that warrant evaluation regardless of COVID history.
• This is not a recommendation for any specific treatment. No supplement, device, or protocol described in social media has FDA approval as a brain-fog treatment.
• This is not evidence that everyone with post-COVID cognitive symptoms has structural brain damage. Most patients improve, often substantially.
• This is not a substitute for neuropsychological testing or medical workup if symptoms are persistent or severe.

A symptom-tracking framework for your appointment

The most useful thing a patient can bring to a clinical appointment is structured data. Vague reports of "brain fog" are difficult to act on; specific, longitudinal data is much easier to evaluate and adjust around.

Daily, briefly

• One sentence describing today's cognitive symptoms.
• Cognitive symptom severity scored 1-10.
• Sleep quality scored 1-10 and total sleep hours.
• Any new medication, supplement, or change in routine.
• Two specific examples of difficulty: e.g. "lost word for 'kitchen,'" "reread page three times," "forgot why I walked into the room."

Weekly

• Average severity score.
• Trend — better, same, or worse than last week.
• Functional impact — missed work, missed appointments, dropped tasks.

For the appointment itself

• Bring the journal.
• Ask about a basic medical workup: thyroid, B12, vitamin D, ferritin, sleep evaluation, blood pressure response to standing.
• Ask whether referral to neurology, neuropsychology, or a long-COVID clinic is appropriate.
• Ask what realistic improvement looks like and on what timeline.

Red flags — see a clinician promptly

The Mayo Clinic, Cleveland Clinic, and the American Academy of Neurology flag the following as reasons to seek prompt medical evaluation rather than self-monitor:

• Sudden cognitive change, not gradual.
• Disorientation to time, place, or person.
• Loss of memory for recent autobiographical events (not just where you put your keys).
• Language deficits — not just word-finding, but inability to form sentences or follow them.
• New weakness on one side, vision change, severe headache, or speech difficulty — seek emergency care.
• Symptoms that interfere with safety: driving impairment, medication errors, falls.
• Symptoms with depression, hopelessness, or thoughts of self-harm — mental-health support is part of cognitive recovery.

Authoritative sources to read directly

• NIH RECOVER Initiative
• CDC Long COVID
• Mayo Clinic: Long-term effects
• Cleveland Clinic: Long COVID
• American Academy of Neurology: Long COVID
• WHO: Post-COVID-19 condition

Related reading on this site